Yet, under federal law, it is labeled "rare" because that definition is based on prevalence —a static snapshot of how many ...

Medically reviewed by Nicholas R. Metrus, MD Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is a progressive neurodegenerative disease. It affects your nerves and muscle tissue and ...

Study shows how ALS-linked mutations disrupt the protein TDP-43 at the atomic level, preventing it from executing its ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Neuralink is crossing the pond. Elon Musk’s brain chip is due to start clinical trials in Great Britain, and he is inviting ...

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death.

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its ...

The Boxing Event brings fighters from across Texas to the ring — all to raise money for gym, nonprofits and raise awareness ...

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, with an incidence of 1 or 2 cases per 100,000 persons and a lifetime risk of 1 case per 800 persons.